Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to describe the mechanism of orthostatic intolerance, relying on cardiovascular physiological studies. The syndrome is of undetermined etiology, but the syndrome causes impairment of a number of young adults, females more than males, with symptoms of tachycardia, fatigue, lightheadedness, palpitations, blurred vision, chest discomfort, difficulty concentrating, and dizziness with the upright posture. It is believed that many different pathophysiological processes can give rise to this disorder.
The purpose of this study is to describe the mechanism of orthostatic intolerance, relying on cardiovascular physiological studies. The syndrome is of undetermined etiology, but the syndrome causes impairment of a number of young adults, females more than males, with symptoms of tachycardia, fatigue, lightheadedness, palpitations, blurred vision, chest discomfort, difficulty concentrating, and dizziness with the upright posture. It is believed that many different pathophysiological processes can give rise to this disorder.
This is not a clinical trial in the classical sense, but an omnibus protocol to allow for disntinct and personalized pathophysiological testing.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients | Other | Patients with orthostatic intolerance |
|
| Healthy Control Subjects | Other | Healthy subjects to determine "normal" response |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DAXOR | Radiation | 131-I-Human Serum Albumin Blood Volume Assessment Kit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Physiological abnormalities in orthostatic intolerance | varied metrics used here | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| blood volume | Blood volume as measured by DAXOR technique | 1 day |
| intrinsic heart rate | Heart rate after IV propranolol and IV atropine |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Robertson, MD | Vanderbilt University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vanderbilt University | Nashville | Tennessee | 37232 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21266211 | Derived | Mustafa HI, Garland EM, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm. 2011 Mar;8(3):422-8. doi: 10.1016/j.hrthm.2010.11.009. Epub 2011 Jan 22. |
| Label | URL |
|---|---|
| Website of the Vanderbilt Autonomic Dysfunction Center | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D013610 | Tachycardia |
| D054972 | Postural Orthostatic Tachycardia Syndrome |
| D054971 | Orthostatic Intolerance |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D000075224 | Cardiac Conduction System Disease |
Not provided
Not provided
| ID | Term |
|---|---|
| D011433 | Propranolol |
| ID | Term |
|---|---|
| D050198 | Phenoxypropanolamines |
| D011412 | Propanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| QSweat | Procedure | Quantitative Sweat Testing |
|
|
| Intrinsic Heart Rate | Drug | Atropine 0.04 mg/kg IV in divided doses Propranolol 0.2 mg/kg IV in divided doses |
|
|
| 1 hour |
| quantitative sweat testing | sweat volumes after a QSweat test | 2 hours |
| residual sympathetic function after pharmacological autonomic blockade | changes in BP after trimethaphan infusions | 3 hours |
| norepinephrine spillover | tritiated norepunephrine spillover data | 3 hours |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D054969 | Primary Dysautonomias |
| D001342 | Autonomic Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D009930 |
| Organic Chemicals |
| D020005 | Propanols |
| D000588 | Amines |
| D009281 | Naphthalenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D011083 | Polycyclic Compounds |